Healthcare
Monday, January 30, 2017
BRIEF-Biofrontera: European Commission extends Ameluz approval to basal cell carcinoma
* European Commission extends Ameluz approval to basal cell carcinoma
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment